Bollino, D.; Ma, X.; Tighe, K.M.; Casildo, A.; Richard, K.; Passaniti, A.; Carter-Cooper, B.; Strovel, E.T.; Emadi, A.
Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. Int. J. Mol. Sci. 2024, 25, 13091.
https://doi.org/10.3390/ijms252313091
AMA Style
Bollino D, Ma X, Tighe KM, Casildo A, Richard K, Passaniti A, Carter-Cooper B, Strovel ET, Emadi A.
Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. International Journal of Molecular Sciences. 2024; 25(23):13091.
https://doi.org/10.3390/ijms252313091
Chicago/Turabian Style
Bollino, Dominique, Xinrong Ma, Kayla M. Tighe, Andrea Casildo, Katharina Richard, Antonino Passaniti, Brandon Carter-Cooper, Erin T. Strovel, and Ashkan Emadi.
2024. "Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia" International Journal of Molecular Sciences 25, no. 23: 13091.
https://doi.org/10.3390/ijms252313091
APA Style
Bollino, D., Ma, X., Tighe, K. M., Casildo, A., Richard, K., Passaniti, A., Carter-Cooper, B., Strovel, E. T., & Emadi, A.
(2024). Calaspargase-Pegol-Mknl Combined with BCL-2 and MCL-1 Inhibition for Acute Myeloid Leukemia. International Journal of Molecular Sciences, 25(23), 13091.
https://doi.org/10.3390/ijms252313091